Heparan sulfate and syndecan-1 are essential in maintaining murine and human intestinal epithelial barrier function - sprookjes - yvandenbroek - TriplyDB

Heparan sulfate and syndecan-1 are essential in maintaining murine and human intestinal epithelial barrier function

Heparan sulfate and syndecan-1 are essential in maintaining murine and human intestinal epithelial barrier function

http://www.wikidata.org/entity/Q36227233

about

Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human genetics Heparanase affects food intake and regulates energy balance in mice Transmembrane and extracellular domains of syndecan-1 have distinct functions in regulating lung epithelial migration and adhesion.Chronic cyclooxygenase-2 inhibition promotes myofibroblast-associated intestinal fibrosis.Versatile role of heparanase in inflammation Dextran fractional clearance studies in acute dengue infection Autism: an emerging 'neuroimmune disorder' in search of therapy.Heparan sulfate proteoglycans.Matrix expansion and syncytial aggregation of syndecan-1+ cells underpin villous atrophy in coeliac disease.High glucose-induced intestinal epithelial barrier damage is aggravated by syndecan-1 destruction and heparanase overexpression.Pathophysiological changes to the peritoneal membrane during PD-related peritonitis: the role of mesothelial cells.Syndecan 1 plays a novel role in enteral glutamine's gut-protective effects of the postischemic gut.Syndecan-1 deficiency promotes tumor growth in a murine model of colitis-induced colon carcinoma The potential of heparanase as a therapeutic target in cancer Syndecan-1 (CD138) deficiency increases Staphylococcus aureus infection but has no effect on pathology in a mouse model of peritoneal dialysis.Plasma-Mediated Gut Protection After Hemorrhagic Shock is Lessened in Syndecan-1-/- Mice.Syndecan-1 is an in vivo suppressor of Gram-positive toxic shock Heparan sulfate on intestinal epithelial cells plays a critical role in intestinal crypt homeostasis via Wnt/β-catenin signaling Glycogene expression in conjunctiva of patients with dry eye: downregulation of Notch signaling.Syndecan-1 shedding facilitates the resolution of neutrophilic inflammation by removing sequestered CXC chemokines.Cell surface-anchored syndecan-1 ameliorates intestinal inflammation and neutrophil transmigration in ulcerative colitis.Mannose supplements induce embryonic lethality and blindness in phosphomannose isomerase hypomorphic mice.Proteoglycans: key regulators of pulmonary inflammation and the innate immune response to lung infection Protein-losing enteropathy: integrating a new disease paradigm into recommendations for prevention and treatment.Molecular functions of syndecan-1 in disease.Heparanase in inflammation and inflammation-associated cancer.Plastic bronchitis in patients with fontan physiology: review of the literature and preliminary experience with fontan conversion and cardiac transplantation.Heparins in ulcerative colitis: proposed mechanisms of action and potential reasons for inconsistent clinical outcomes.Applications of capillary electrophoresis electrospray ionization mass spectrometry in glycosaminoglycan analysis.Heparanase: a rainbow pharmacological target associated to multiple pathologies including rare diseases.Heparanase regulation of cancer, autophagy and inflammation: new mechanisms and targets for therapy.Over-expression of human endosulfatase-1 exacerbates cadmium-induced injury to transformed human lung cells in vitro.Protein losing enteropathy: comprehensive review of the mechanistic association with clinical and subclinical disease states.Low serum 25-hydroxyvitamin D levels and secondary hyperparathyroidism in Fontan patients.Patching a leaky intestine.Heparanase: From basic research to therapeutic applications in cancer and inflammation.New thinking about postoperative hypoalbuminemia: a hypothesis of occult protein-losing enteropathy.Enoxaparin improves the course of dextran sodium sulfate-induced colitis in syndecan-1-deficient mice.Advances in the pathogenesis and possible treatments for multiple hereditary exostoses from the 2016 international MHE conference.Vertebrate food products as a potential source of prion-like α-synuclein.

P2860

Q21131205-8FB0AE91-DFCA-4FD0-A9E7-4203F6519B17 Q28730908-4237CC10-6411-47F1-A671-486A7300F73A Q30525661-13C6B927-D4E5-4DDA-9558-9926D33AA489 Q33708065-81DB2FD1-7CC9-4DBB-8C02-443B32A7E45C Q33770777-CF230CC9-4649-447C-9608-7375F7564F4C Q34009077-D82DA5B3-9564-437B-9C26-C852E4F3A7F9 Q34994653-20390E72-E4D5-4070-8D9E-098E2A227568 Q35059448-AFF9F5A4-948D-4080-99B0-2A8E1038BCCC Q35242505-2D4C99F5-5174-42CF-85DC-2AB630E04ED5 Q35695593-C952A9DD-DBC7-4837-85DC-AAD3E0B9EB4C Q35915748-CDBDDEA0-9D87-41FE-85E4-BDDE3EF004A8 Q36081681-048370E0-4919-4311-BB22-F20DF7C8F7CE Q36325314-25832BD2-F06C-48E2-AAF5-A0A8BADC11F7 Q36452903-FF6B1946-A025-4C38-9BE6-CB887DC014C4 Q36531194-4E9BB0FE-BF82-4768-BB6F-33AD0C3A86F0 Q36752489-86D5B257-752C-46DC-B0FE-57EECB5BDDBD Q36761832-A2E08E88-713A-436A-8693-2C3CA2EBEE4A Q37093622-1D978FE3-4927-43E8-B281-A00E7B79F082 Q37219269-BF50B136-BC89-4D90-8D7B-8A389F7AC929 Q37373049-92775B6C-F49D-412A-B660-268D00F77A5F Q37539888-72D47773-168B-4DEE-BDD2-41B524381DD8 Q37657159-E865AAC8-E86E-49C6-A4A1-DC875FDBD950 Q37760881-A0EC0927-9817-46DE-A3D8-276E426A7C16 Q37846895-0451588C-7B46-4A5D-A71D-3F88B11C21A2 Q37950202-B88E7AE0-196C-4118-A012-B511F340B750 Q38080632-C1C7C145-4E0E-4863-A475-ECAA37AB2522 Q38117343-C46CA2AF-A7E8-409E-9450-8763CAD4A98E Q38574126-4E3BD941-706E-4949-A8F0-D3BC9032B81E Q38678456-D35D376A-0839-4670-93AF-AF27310461CF Q38801721-4A35E0F7-8297-43F0-BD12-165922DD03DB Q38985052-10DA771F-0DB8-4CF0-8BF1-D5F990868BC2 Q39273931-20353384-42F0-48B9-914E-33F1136AC707 Q40112268-0E002379-471F-4AA5-A9B1-261D69B0F5A9 Q40637231-50A858A4-06E5-489B-AD0F-B2D1A9A4D2A7 Q41991004-F8E903CB-34B7-48E5-BDCF-572C85B021BF Q42587945-20BEE17A-4DA4-4090-9FB0-400409F91C2F Q42729123-9499FDB3-3E47-4147-9782-520BC7E5727C Q42947929-54AA6BA5-71D0-4607-A224-74377816BBAE Q46128938-5BB835A7-F636-48D8-BB82-CA54D13FCA4F Q46252338-A928BE34-5D8C-4234-9134-E83C30ECE0C2

P2860

Heparan sulfate and syndecan-1 are essential in maintaining murine and human intestinal epithelial barrier function

http://www.wikidata.org/entity/Q36227233

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Heparan sulfate and syndecan-1 ...... al epithelial barrier function

@ast

Heparan sulfate and syndecan-1 ...... al epithelial barrier function

@en

type

label

Heparan sulfate and syndecan-1 ...... al epithelial barrier function

@ast

Heparan sulfate and syndecan-1 ...... al epithelial barrier function

@en

prefLabel

Heparan sulfate and syndecan-1 ...... al epithelial barrier function

@ast

Heparan sulfate and syndecan-1 ...... al epithelial barrier function

@en

P1433

Q36227233-8B5A16E0-7F65-4CF7-9931-0934EB5B7A9A

P1476

Q36227233-121CF7B0-29A1-4D82-9530-134881B23D8A

P2093

Q36227233-21EB9E82-FEE0-440A-AF4D-4BD682EF709C

Q36227233-494CD691-3B2D-47F9-BACC-B0BC85A96393

Q36227233-4D1E317F-F3AE-4651-9AAB-2859A866ED52

Q36227233-579C2408-FA07-49DF-8370-74E552D9E6AF

Q36227233-A0977D37-27D9-4749-91D3-348C3D116E20

Q36227233-C810D96F-F0F8-4489-AA5F-65B0AA38FA42

Q36227233-EF8D7F55-978F-4CE8-82CB-625DA206BC20

P2860

Q36227233-0041D577-057E-40C9-A3B6-06AD8C946A54

Q36227233-0205A9DD-4EC9-4BA1-825E-63C1479FC709

Q36227233-02FF0EA6-BDDF-4994-BB5D-D6AC56E6DC3A

Q36227233-06A14553-D28D-49B8-B986-B611EFBC5203

Q36227233-0CED4AA5-A50D-4038-9C02-6A0C3198AD93

Q36227233-0D88B971-74B4-40D0-89C1-24B6B54454C9

Q36227233-10156F3C-7056-4E48-914F-4EA5495D7345

Q36227233-10AFC1C3-E62E-41EB-8E84-841E83347016

Q36227233-1CBAC286-8AC4-4F74-9ABC-E0D4CA7C6101

Q36227233-279B69AD-4BE8-4108-B074-DF576918EECB

P304

Q36227233-730A36EA-7A8B-4C51-A80D-08291275DF09

P31

Q36227233-F8CE800A-7D89-4E3D-93DC-A9928336ED5E

P356

Q36227233-C88824D2-3E72-4445-8B27-A32892746252

P407

Q36227233-2B63FDFA-85D6-413C-8CE2-7C57D47A63C3

P433

Q36227233-05D3D1AB-9B2A-47BF-A122-9765E18B60AF

P478

Q36227233-1EF22698-BDA2-4616-9E25-CDF1BF41EF8D

P50

Q36227233-1AD7B2B4-9AF2-4DEC-B52C-8A272B9F6C46

P577

Q36227233-491B50BD-F7BB-4C36-98E4-1FC920624C53

P5875

Q36227233-7C754B0E-6C6A-4713-A998-86F263811666

P698

Q36227233-D97FA535-A86D-465A-A060-8B9BC817360F

P932

Q36227233-D1C1CC58-00A2-4086-A789-B0EC0CF057C3

P356

P1433

Journal of Clinical Investigation

P1476

Heparan sulfate and syndecan-1 ...... al epithelial barrier function

@en

P2093

Camilla Salvestrini

http://www.w3.org/2001/XMLSchema#string

Jeffrey D Esko

http://www.w3.org/2001/XMLSchema#string

Jin-Ping Li

http://www.w3.org/2001/XMLSchema#string

Lars Bode

http://www.w3.org/2001/XMLSchema#string

Pyong Woo Park

http://www.w3.org/2001/XMLSchema#string

Simon Murch

http://www.w3.org/2001/XMLSchema#string

Yu Yamaguchi

http://www.w3.org/2001/XMLSchema#string

P2860

Reduced heparan sulfate accumulation in enterocytes contributes to protein-losing enteropathy in a congenital disorder of glycosylation

Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy

Protein-losing enteropathy in patients with Fontan circulation: is it triggered by infection?

Congenital disorders of glycosylation: review of their molecular bases, clinical presentations and specific therapies

Interferon-gamma binds to heparan sulfate by a cluster of amino acids located in the C-terminal part of the molecule

Disruption of gastrulation and heparan sulfate biosynthesis in EXT1-deficient mice

Mammalian brain morphogenesis and midline axon guidance require heparan sulfate

Mice deficient in Ext2 lack heparan sulfate and develop exostoses

Order out of chaos: assembly of ligand binding sites in heparan sulfate

Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration.

P304

229-238

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI32335

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

118

http://www.w3.org/2001/XMLSchema#string

P50

Hudson H. Freeze

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5784596

http://www.w3.org/2001/XMLSchema#string

P698

18064305

http://www.w3.org/2001/XMLSchema#string

P932

2117765

http://www.w3.org/2001/XMLSchema#string